Form 4: BrightSpring Health Services CEO Jon Rousseau Reports Stock and Option Grants
SEC Form 4 Filing
Jon Rousseau, CEO of BrightSpring Health Services, reports the acquisition of restricted stock units and stock options.
Summary
- Jon Rousseau, Chairman, President, and CEO of BrightSpring Health Services, filed a Form 4 detailing changes in beneficial ownership.
- On March 17, 2025, Rousseau was granted 345,424 restricted stock units (RSUs) that vest in twelve equal quarterly installments starting April 25, 2025.
- Each RSU represents the right to receive one share of common stock upon settlement.
- Rousseau also acquired 733,496 stock options with an exercise price of $17.45, vesting in twelve equal quarterly installments commencing April 25, 2025, and expiring on March 17, 2035.
- Following these transactions, Rousseau directly owns 1,233,020 shares of common stock (including shares underlying RSUs) and indirectly owns 369,763 shares through the Rousseau Family Trust.
- The filing also includes a Power of Attorney, effective October 29, 2024, authorizing Jon Rousseau, Jennifer Phipps, and Allison Brown to act on the undersigned's behalf for SEC filings related to BrightSpring Health Services.
Sentiment
Score: 6
Explanation: The document is a routine SEC filing related to executive compensation. It's neutral in sentiment, reflecting standard corporate governance practices.
Positives
- The grant of RSUs and stock options to the CEO could be seen as an incentive to align his interests with those of the shareholders.
- The vesting schedules for the RSUs and options (quarterly installments commencing April 25, 2025) encourage long-term commitment from the CEO.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedules of the RSUs and stock options.
Industry Context
Executive compensation through stock options and RSUs is a common practice in the healthcare industry to incentivize performance and align management interests with shareholders.
Comparison to Industry Standards
- Stock option and RSU grants are standard compensation practices for executives in publicly traded healthcare companies.
- Companies like UnitedHealth Group, CVS Health, and Humana also utilize similar equity-based compensation plans to incentivize their leadership teams.
- The vesting schedules and exercise prices are generally in line with industry norms, designed to reward long-term value creation.
Stakeholder Impact
- The grant of equity to the CEO aligns his interests with shareholders, potentially driving long-term value creation.
- Employees may view the equity grants positively, as it signals confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 2024-10-29 | Date of Power of Attorney execution. |
| 2025-03-17 | Date of RSU and stock option grants. |
| 2025-03-19 | Form 4 filing date. |
| 2025-04-25 | Commencement date for quarterly vesting of RSUs and stock options. |
| 2035-03-17 | Expiration date of stock options. |
Keywords
Form 4, BrightSpring Health Services, Jon Rousseau, RSU, Stock Options, Beneficial Ownership, SEC Filing, Power of Attorney
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.